Cleared Traditional

Hyperfine Point-Of-Care Magnetic Resonance Imaging (POC MRI) Scanner System (K201722) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K201722 · Hyperfine Research, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
49d
Days
Class 2
Risk

K201722 is an FDA 510(k) clearance for the Hyperfine Point-Of-Care Magnetic Resonance Imaging (POC MRI) Scanner System. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Hyperfine Research, Inc. (Guildford, US). The FDA issued a Cleared decision on August 11, 2020 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hyperfine Research, Inc. devices

Submission Details

510(k) Number K201722 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2020
Decision Date August 11, 2020
Days to Decision 49 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 107d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 548
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K201722.
Magnetom Aera, Magnetom Skyra, Magnetom Prisma/Prisma fit
K202014 · Siemens Medical Solutions USA, Inc. · Sep 2020
SIGNA Artist
K202238 · Ge Healthcare (Tianjin) Company Limited · Sep 2020
FIRMM
K201141 · Nous Imaging, Inc. · Aug 2020
SyMRI
K201616 · Syntheticmr AB · Jul 2020
Vantage Orian 1.5T, MRT-1550, V6.0 with AiCE Reconstruction Processing Unit for MR
K193097 · Canon Medical Systems Corporation · Jul 2020
Resoundant Acoustic Driver System
K201389 · Resoundant, Inc. · Jul 2020